InsidersTradesSigma
Follow the 셀로맥스사이언스 stock price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 셀로맥스사이언스 has logged 3 insider filings. Market capitalisation: €45.4bn. The latest transaction was disclosed on 6 April 2026 (Purchase). Among the most active insiders: 서지완. All data is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
Cellomax Science es una empresa del sector de la salud y farmacéutico, que cotiza en el mercado XKRX. Se especializa en el desarrollo de soluciones innovadoras para el campo médico.